Oral Drug Delivery Market to Continue Growth to a Potential $52 billion by 2010, Says New Report Available from Piribo.com

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added a report on the growth potential for oral drug delivery to its collection. “Drug Delivery Markets, Vol. 1: Oral Delivery” forecasts the market will grow at a compound annual growth rate of 10% over the next several years reaching upwards of $52 billion by 2010.
The oral drug delivery market is the largest sector within the total drug delivery arena. It’s made up of both pharmaceuticals utilizing oral delivery technologies as well as the technologies themselves. This study shows 2006 world revenues at the manufacturer’s level exceeding $35 billion for the overall oral drug delivery market with more than $3 billion coming from the delivery technology sector alone.

The largest contributors to the overall market were the controlled/sustained-release segment and the delayed-release segment, but growth continues to be fueled by the introduction of many line extensions in both the controlled-release and fast-dissolving product segments. Broader market issues are also fueling growth.

This comprehensive study includes a detailed market overview with market size and forecasts, profiles of legacy companies within the market as well as new entrants, challenges faced by oral-delivery technology companies, key trends and demographics impacting the global marketplace, and a unique analysis of the value of technology licensing as a portion of the overall modified oral delivery market..

“Drug Delivery Markets, Vol. 1: Oral Delivery,” is available in PDF format from Piribo. For more information go to: http://tinyurl.com/3ch2mo

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.